Bristol Myers and Celgene in $74bn pharmaceutical merger

Home › Bristol Myers and Celgene in $74bn pharmaceutical merger

Two leading US cancer drug companies announce a blockbuster tie-up valued at more than $74bn.

27.11	Loyalty cards offer genuine savings, says watchdog
27.11	Aston Martin issues second profit warning in two months
27.11	Online slots gambling to be limited to 5 per spin
26.11	Black Friday shoppers warned to be wary of deals
26.11	Trump proves he is serious on tariffs - but it's not about trade
26.11	Sports service SPOTV adopts Zixi for affiliate delivery
26.11	'I want to get a job but I don't know how'
26.11	EQT to sell Melita to Goldman Sachs Alternatives
Consumer Goods and Services »

je.st